CUE
Cue Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.44
−0.83%0
Insider buys (3m)
11
Insider sells (3m)
-$2.0M
Net value (3m)
-6.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 28, 2026 | Sarraf Pasha · director | A-Award | 18,400 | $0.00 |
| Aug 28, 2026 | Garzone Pamela · director | A-Award | 18,900 | $0.00 |
| Aug 17, 2026 | Meluzio Michael Vincent · officer: VP, Prin. Accounting Officer | Sale | 4,106 | $30 |
| Aug 17, 2026 | Meluzio Michael Vincent · officer: VP, Prin. Accounting Officer | Sale | 1,519 | $29 |
| Aug 17, 2026 | Meluzio Michael Vincent · officer: VP, Prin. Accounting Officer | M-Exempt | 13,647 | $0.00 |
| Aug 17, 2026 | Ray Sumita · officer, other: Chief Legal Compliance Officer | Sale | 4 | $31 |
| Aug 17, 2026 | Ray Sumita · officer, other: Chief Legal Compliance Officer | M-Exempt | 18,196 | $0.00 |
| Aug 17, 2026 | Ray Sumita · officer, other: Chief Legal Compliance Officer | Sale | 2,383 | $29 |
| Aug 17, 2026 | Ray Sumita · officer, other: Chief Legal Compliance Officer | Sale | 6,442 | $30 |
| Aug 17, 2026 | Meluzio Michael Vincent · officer: VP, Prin. Accounting Officer | Sale | 3 | $31 |
| Aug 14, 2026 | Lin Shao-Lee · director, officer: Chief Executive Officer | Sale | 10,460 | $29 |
| Aug 14, 2026 | Lin Shao-Lee · director, officer: Chief Executive Officer | M-Exempt | 109,179 | $0.00 |
| Aug 14, 2026 | Lin Shao-Lee · director, officer: Chief Executive Officer | Sale | 34,225 | $27 |
| Aug 14, 2026 | Lin Shao-Lee · director, officer: Chief Executive Officer | Sale | 5,775 | $28 |
| Aug 14, 2026 | Lin Shao-Lee · director, officer: Chief Executive Officer | Sale | 5,423 | $27 |
| Aug 14, 2026 | Lin Shao-Lee · director, officer: Chief Executive Officer | Sale | 2,375 | $28 |
| Aug 3, 2026 | Ahlers James M · officer: Chief Financial Officer | A-Award | 25,500 | $0.00 |
| Aug 3, 2026 | Ahlers James M · officer: Chief Financial Officer | A-Award | 51,000 | $30 |
| Jul 30, 2026 | Lin Shao-Lee · director, officer: Chief Executive Officer | A-Award | 90,906 | $0.00 |
| Jul 30, 2026 | Lin Shao-Lee · director, officer: Chief Executive Officer | A-Award | 45,453 | $11 |
| Jul 15, 2026 | Borie Dominique Christian · officer, other: Chief Medical Officer | A-Award | 63,000 | $31 |
| Jul 15, 2026 | Borie Dominique Christian · officer, other: Chief Medical Officer | A-Award | 31,500 | $0.00 |
| Jul 10, 2026 | Garzone Pamela · director | A-Award | 21,800 | $0.00 |
| Jul 10, 2026 | Camardo Daniel A. · director | A-Award | 21,800 | $0.00 |
| Jul 10, 2026 | Sarraf Pasha · director | A-Award | 21,800 | $0.00 |
| Jul 10, 2026 | Meehan Viola Mong · director | A-Award | 21,800 | $0.00 |
| Jul 10, 2026 | Meluzio Michael Vincent · officer: VP, Prin. Accounting Officer | A-Award | 40,942 | $0.00 |
| Jul 10, 2026 | Ray Sumita · officer, other: Chief Legal Compliance Officer | A-Award | 54,589 | $0.00 |
| Jul 10, 2026 | Lin Shao-Lee · director, officer: Chief Executive Officer | A-Award | 327,537 | $0.00 |
| Jun 8, 2026 | Camardo Daniel A. · director | A-Award | 1,626 | $22 |
Institutional positioning
13F filings over the trailing two quarters
New 30Increased 8Reduced 43Sold out 20
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLEICHROEDER LP | Unchanged | 6,819,164 | May 14, 2026 |
| CATALYTIC WEALTH RIA, LLC | Unchanged | 4,631,644 | May 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,457,452 | May 15, 2026 |
| LION POINT CAPITAL, LP | Unchanged | 2,202,854 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 1,064,690 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 543,585 | May 8, 2026 |
| ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | Unchanged | 478,500 | Apr 28, 2026 |
| BLACKROCK, INC. | Reduced | 449,161 | May 13, 2026 |
| TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC | Reduced | 397,421 | May 11, 2026 |
| Bleichroeder LP | Reduced | 370,682 | Aug 13, 2026 |
| ANGELES WEALTH MANAGEMENT, LLC | Unchanged | 310,000 | May 6, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | New Position | 292,144 | Aug 14, 2026 |
| ADVISORY RESEARCH INC | Unchanged | 257,225 | May 14, 2026 |
| STIFEL FINANCIAL CORP | Unchanged | 246,556 | May 12, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 213,828 | May 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 28, 2026